Clinical Trial | AT13387 (HSP90 inhibitor) × 2 cycles with concurrent Crizontinib.

pompeysh1a
pompeysh1a Member Posts: 11
edited January 2020 in General Discussion
I simply hated this trial that I participated in from May 15, 2015 to July 10, 2015. My lymphedema became worse, I became dehydrated. Constipation was a nightmare. I was fatigued more. This trial hindered my quality of life.